Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januari 2022 News Veterinary Maximum residue limit Medicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januari 2022 News Human COVID-19 COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januari 2022 News Human COVID-19 Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januari 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines EMA welcomes EU Commissioner for Health and Food Safety 13 januari 2022 News Corporate COVID-19 Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januari 2022 News Human Clinical trials Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 januari 2022 News Human COVID-19 Vaccines Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 januari 2022 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19 10 januari 2022 News Human COVID-19 Medicines Emer Cooke’s end-of-year message 22 december 2021 News Corporate COVID-19 1 … 46 47 48 49 50 Page 50 of 379 51 52 53 54 … 379
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januari 2022 News Veterinary Maximum residue limit Medicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januari 2022 News Human COVID-19
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januari 2022 News Human COVID-19 Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januari 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januari 2022 News Human Clinical trials
Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 januari 2022 News Human COVID-19 Vaccines
Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 januari 2022 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19 10 januari 2022 News Human COVID-19 Medicines